+ Watch ELGX
on My Watchlist
The Company develops, manufactures, sells and markets minimally invasive therapies for the treatment of cardiovascular disease.
Bought this one in my personal portfolio. Endologix, Inc. is a developer of vascular disease treatments, specifically abdominal aortic aneurysms.The company’s primary product is a next-generationendoluminal stent graft, a minimally invasive device used to help the 1.7 million Americans with weakened aortas. The Baby Boomers will need plenty of treatments to live to their life expectancy and the growth potential of this company is outstanding.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions